Evaluation of a Peer Counseling Breastfeeding Support Program for Mother-preterm Infant Dyads (ALAIS)

November 18, 2025 updated by: Hospices Civils de Lyon

Breastfeeding Peer Counselling for Mothers of Preterm Neonates: a Stepped- Wedge Cluster Randomized Controlled Trial

Breastfeeding has a fundamental impact on the short-, medium- and long-term health of children and has an important impact on women's health. Breastfeeding protects against gastrointestinal and respiratory illnesses and is associated with better cognitive development in childhood, particularly in preterm infants. Despite these potential benefits, preterm infants experience lower rates of breastfeeding initiation and continuation compared to term infants.

The use of breastfeeding peer support initiatives, in which advice is given by experienced and trained peer counselors, is an effective way to promote and support breastfeeding, regardless of a woman's socioeconomic status. Several small studies have shown that breastfeeding peer support initiatives were effective for preterm infants and that this efficacy was increased by the co-intervention of lactation consultants.

The purpose of this study is to develop and to evaluate the effectiveness of a breastfeeding support program among mother-preterm infant dyads in Europe, by evaluating the impact of the intervention on 1) breastfeeding rates, 2) morbidity and mortality during the hospitalization, 3) children's cognitive development and behavior 4) mothers' mental health, 4) costs benefits.

The breastfeeding support program will include peer counselors under the supervision of lactation consultants. Breastfeeding counselors will be voluntary mothers who have had a positive breastfeeding experience with at least one preterm infant. After a training course, they will meet the future or new mothers by face-to-face and share their experiences at least once a week during hospitalization and provide phone support up to 1 month after discharge from hospital.

The study design will be a stepped wedge cluster trial conducted in 8 NICU in Europe (France, Switzerland and Belgium). Infants and mothers will be followed up from the time of hospitalization in the maternity and NICU up to 6 months after the discharge. The cost analysis will be performed in a subgroup of mother-preterm infant dyads that will be followed up at 24-months after their discharge

Study Overview

Study Type

Interventional

Enrollment (Actual)

1774

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rocourt, Belgium
        • CHC Clinique St-Vincent
      • Bron, France
        • Hopital Femme Mere Enfant
      • Gleizé, France
        • Hôpital Nord Ouest - Villefranche
      • Grenoble, France
        • CHU de Grenoble
      • Pierre-Bénite, France
        • CH Lyon Sud
      • Toulouse, France
        • Hôpital des Enfants
    • Réunion
      • Saint-Denis, Réunion, France, 97400
        • CHU site Félix Guyon
      • Lausanne, Switzerland
        • CHU vaudois

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 8 months (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • any infant born <35 weeks' gestation,
  • hospitalised in NICU before 24 hours old
  • and younger than 168 hours (7 days) old.

Exclusion Criteria:

  • infant with foetal malformation that is life-threatening
  • infant with medical contraindication for breastfeeding
  • parent(s)' non-consent to be involved in the study
  • mother with prolonged medical contraindication for breastfeeding
  • mother with psychiatric disorders making breastfeeding support impossible
  • if no communication is possible with the mother
  • if the level of communication with the mother does not allow breastfeeding support, with or without a third party

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Breastfeeding support program
The mother-infant dyads in the intervention arm will receive breastfeeding mother-to-mother support from the hospitalization in the maternity and NICU up to 1 month after discharge. The intervention will be in addition to the usual or routine care. Breastfeeding counselors will be voluntary mothers who breastfed their own preterm infant (aged between 6 months and 5 years at the time of the study) for a minimum of 2 months, and who have had a positive personal breastfeeding experience, and who have undertaken a training course.
Other: Usual or routine care
The mother-infant dyads in the control arm will continue to receive the usual/routine care provided by participating centers during the hospitalization and Mother and Infant Protection service after discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breastfeeding continuation rates
Time Frame: at corrected postnatal age of 2 months
Breastfeeding will be defined as the consumption of any mother's own milk. It will be classed as exclusive when all of the fed milk is the mother's own milk, or mixed when it will be completed by other milk and/or food.
at corrected postnatal age of 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of breastfeeding initiated
Time Frame: at 2 months of corrected age
at 2 months of corrected age
Breastfeeding rate
Time Frame: at 2 months of corrected age
at 2 months of corrected age
Breastfeeding rate
Time Frame: at the end of NICU stay
at the end of NICU stay
Breastfeeding rate
Time Frame: at 6 months of corrected age
at 6 months of corrected age
Breastfeeding duration
Time Frame: at 6 months of corrected age
at 6 months of corrected age
Neonatal severe complications
Time Frame: at 36 weeks of corrected age
Morbidity outcomes will include intraventricular haemorrhage grade≥3, periventricular leucomalacia, sepsis (proven or clinical), persistent ductus arteriosus requiring treatment, necrotising enterocolitis grade≥2, and bronchopulmonary dysplasia (need of oxygen and/or ventilation support at 36 weeks of corrected age), retinopathy of prematurity grade>2.
at 36 weeks of corrected age
Death rates
Time Frame: at 36 weeks of corrected age
Morbidity outcomes will include intraventricular haemorrhage grade≥3, periventricular leucomalacia, sepsis (proven or clinical), persistent ductus arteriosus requiring treatment, necrotising enterocolitis grade≥2, and bronchopulmonary dysplasia (need of oxygen and/or ventilation support at 36 weeks of corrected age), retinopathy of prematurity grade>2.
at 36 weeks of corrected age
Infant behaviours
Time Frame: at corrected postnatal age of 6 months
Behavior will be assessed by the validated Infant Behavior questionnaire completed by mothers.
at corrected postnatal age of 6 months
Mother-Infant bonding
Time Frame: at corrected postnatal age of 6 months
Disabilities will include cerebral palsy, mental retardation assessed by the developmental quotient less than 85 on the Brunet- Lézine scale, and visual and hearing deficits. -Infant bonding assessed by the Mother-Infant Bonding Scale (MIBS)
at corrected postnatal age of 6 months
Disability rate
Time Frame: at corrected postnatal age of 24 months
Disabilities will include cerebral palsy, mental retardation assessed by the developmental quotient less than 85 on the Brunet- Lézine scale, and visual and hearing deficits.
at corrected postnatal age of 24 months
Neurodevelopment rate by Brunet Lézine scale
Time Frame: at corrected postnatal age of 24 months
at corrected postnatal age of 24 months
Anxiety by the Hospital Anxiety and Depression Scale (HADS)
Time Frame: at corrected postnatal age of 6 months
at corrected postnatal age of 6 months
Depression by the Edinburgh Postnatal Depression Scale.
Time Frame: at corrected postnatal age of 6 months
at corrected postnatal age of 6 months
Posttraumatic stress by the Post-traumatic stress disorder Checklist version DSM-5 (PCL-5)
Time Frame: at corrected postnatal age of 6 months
at corrected postnatal age of 6 months
Parents stress by the Parenting Stress Index Fourth Edition Short Form (PSI-4 SF
Time Frame: at corrected postnatal age of 6 months
at corrected postnatal age of 6 months
Costs effectiveness of breastfeeding
Time Frame: up to first two years of life
Costs will include initial hospitalization, hospital readmissions, outpatient visits and tests.
up to first two years of life
cost consequence of breastfeeding
Time Frame: up to first two years of life
Costs will include hospitalization rate and mortality between the two strategies.
up to first two years of life
Feasibility of the breastfeeding support program
Time Frame: 24 months
To assess the feasibility of the intervention, we will depict : - the socio-demographic characteristics of breastfeeding counselors - and the number of contacts between mothers and breastfeeding counselors (frequency and duration) and the information
24 months
Acceptability of the breastfeeding support program
Time Frame: 24 months

To assess the acceptability of the breastfeeding support program, we will collect :

  • the perception of breastfeeding support by mothers and their spouses, by staff members (lactation consultant, nurses) in each participating centers and by breastfeeding counselors.
  • the number of mothers who refuse to be managed by a breastfeeding counselors and their reasons,
  • the duration of each breastfeeding counselor intervention and the number of mothers who will stop the intervention before 1 month after the hospital discharge.
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sophie Laborie, MD, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Bron

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 5, 2018

Primary Completion (Actual)

December 22, 2022

Study Completion (Actual)

December 22, 2022

Study Registration Dates

First Submitted

May 2, 2017

First Submitted That Met QC Criteria

May 16, 2017

First Posted (Actual)

May 17, 2017

Study Record Updates

Last Update Posted (Estimated)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 18, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant Premature

Clinical Trials on breastfeeding mother-to-mother support

Subscribe